|Articles|September 1, 2001
Scourge of time - elderly pay price of living longer
Aging may be unavoidable, but timely treatment and prevention can keep skin healthy
Phase 3 OptIMMize-1 findings show sustained skin clearance, itch reduction, and quality-of-life improvements with risankizumab through 52 weeks.